IHTDESTINY® SISTEMA DE STENTCORONARIO CON ELUCIÓN DESIROLIMUS - COFEPRIS Registration 1349C2021 SSA
Access comprehensive regulatory information for IHTDESTINY® SISTEMA DE STENTCORONARIO CON ELUCIÓN DESIROLIMUS (IHTDESTINY® CORONARY STENT SYSTEM WITH ELUTION DESIROLIMUS) in the Mexico medical device market through Pure Global AI's free database. This Clase III medical device is registered under COFEPRIS analysis ID 1349C2021 SSA and manufactured by MEDSTENT, S.A. DE C.V.. The device was registered on June 09, 2021.
This page provides complete registration details including product type (II. PROSTHETICS, ORTHOSES AND FUNCTIONAL AIDS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL SISTEMA DE STENT CORONARIO CONELUCIÓN DE SIROLIMUS IHTDESTINY® ESTÁINDICADO PARA SU UTILIZACIÓN EN LAANGIOPLASTIA CORONARIA TRANSLUMINALPERCUTÁNEA (ACTP) PARA LA DILATACIÓNPERMANENTEDELAPARTEESTENÓTICADEUNAARTERIACORONARIANATIVA,MEDIANTELACOLOCACIÓN DEUN STENT CORONARIOCON EL FIN DE MEJORAR LA PERFUSIÓNMIOCÁRDICA.
THE SIROLIMUS IHTDESTINY® CORONARY STENT SYSTEM IS INDICATED FOR USE IN TRANSLUMINALPERCUTANEOUS CORONARY ANGIOPLASTY (PTCA) FOR PERMANENT DILATION OF THE STENOTIC PART OF A CORONARY ARTERY BY CORONARY STENTING TO IMPROVE MYOCARDIAL PERFUSION.